Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

Technology appraisal guidance
Reference number: TA170
Published: 22 April 2009

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders
27 February 2012
(64.77 Kb 18 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 February 2012